Gayatin, Krizzia Jane P.

HRN: 19-92-03  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/16/2022
CEFUROXIME 1.5GM (VIAL)
10/17/2022
10/17/2022
IV
1.5g
LD
Preop Prophylaxis
Waiting Final Action 
10/17/2022
CEFUROXIME 1.5GM (VIAL)
10/17/2022
10/18/2022
IV
1.5gm
TID X 4 More Doses
Post OP Prophylaxis
Waiting Final Action 
10/18/2022
CEFUROXIME 500MG (TAB)
10/18/2022
10/25/2022
ORAL
500mg
Q12
S/P Pelvic Lap
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: